Wednesday, December 25th, 2024

Parkway Life REIT Announces 5.00 Cents Advanced Distribution for Unitholders






Parkway Life REIT Announces Advanced Distribution Amid New Unit Issuances


Parkway Life REIT Announces Advanced Distribution Amid New Unit Issuances

Parkway Trust Management Limited, the manager of Parkway Life Real Estate Investment Trust (PLife REIT), has declared an actual Advanced Distribution of 5.00 cents per unit for the period from 1 July 2024 to 31 October 2024. This follows the issuance of new units under a private placement.

Key Points of the Announcement

  • The distribution amount is broken down into:
    • Taxable income distribution: 3.44 Singapore cents
    • Tax-exempt income distribution: 0.80 Singapore cents
    • Capital distribution: 0.76 Singapore cents
  • Unitholders whose securities accounts with The Central Depository (Pte) Limited are credited with units as of 5.00 p.m. on the Advanced Distribution Record Date will be entitled to this distribution.
  • The Advanced Distribution will be paid on Tuesday, 26 November 2024.
  • Holders of the new units issued under the private placement will not be entitled to the Advanced Distribution.

Important Information for Shareholders

Shareholders should note that the next distribution following this Advanced Distribution will cover PLife REIT’s distributable income for the period from 1 November 2024 to 31 December 2024. After this period, semi-annual distributions will resume unless otherwise announced.

It is important for shareholders to be aware that the value of units and the income derived from them may fluctuate. Units are not obligations of, deposits in, or guaranteed by the Manager or any of its affiliates. An investment in units carries risks, including the potential loss of the principal amount invested. Investors should not place undue reliance on forward-looking statements, which are subject to risks and uncertainties.

Risks and Forward-Looking Statements

This announcement includes forward-looking statements that involve risks and uncertainties. Actual future performance, outcomes, and results may differ materially from those expressed in these statements due to various factors, including general industry and economic conditions, interest rate trends, and competition, among others. Investors are advised to exercise caution and not rely excessively on these statements.

The past performance of PLife REIT is not necessarily indicative of its future performance. The units are intended to be traded on the SGX-ST, and there is no guarantee of a liquid market for the units.

Regulatory and Legal Notices

This announcement is not for release, publication, or distribution, directly or indirectly, in or into the United States, European Economic Area, the United Kingdom, Canada, Japan, or Australia. The securities mentioned have not been and will not be registered under the United States Securities Act of 1933, and may not be offered or sold in the United States without an applicable exemption.

This announcement has not been reviewed by the Monetary Authority of Singapore. The new units are prescribed capital markets products and excluded investment products as defined in the relevant Singapore regulations.

Disclaimer: This article is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Investment in units involves risks, and investors should consider these risks before making any investment decisions.


Keppel DC REIT Launches S$1 Billion Equity Fund Raising to Acquire Strategic Data Centers

Keppel DC REIT Announces Major Equity Fund Raising: What Investors Need to Know Keppel DC REIT Announces Major Equity Fund Raising: What Investors Need to Know Keppel DC REIT Management Pte. Ltd. has launched...

17LIVE Group Proposes Major ESOP Expansion and Share Buyback Amid Revenue Decline: Key Shareholder Concerns Addressed

17LIVE’s Strategic Moves: Share Buybacks and ESOP Amendments Aim to Boost Shareholder Value 17LIVE’s Strategic Moves: Share Buybacks and ESOP Amendments Aim to Boost Shareholder Value 17LIVE Group Limited has released a detailed response...

Hyphens Pharma Reports Mixed Q3 Results: Revenue Up, Profit Down

Hyphens Pharma Reports Strong Growth with 22.1% Revenue Increase in 9M2024 Hyphens Pharma Reports Strong Growth with 22.1% Revenue Increase in 9M2024 Hyphens Pharma International Limited has released their quarterly business update for the...